The primary medications for OCD are a class of antidepressants called SSRIs, which increase serotonin activity in the brain. Five medications currently have FDA approval for OCD: fluoxetine (Prozac), sertraline (Zoloft), fluvoxamine (Luvox), paroxetine (Paxil), and clomipramine (Anafranil). Two additional SSRIs, citalopram (Celexa) and escitalopram (Lexapro), are frequently prescribed off-label and work through the same mechanism.
Why OCD Medications Differ From Depression Medications
OCD and depression often respond to the same drugs, but the way those drugs are used differs significantly. OCD typically requires higher doses and longer timelines before symptoms start to improve. For fluoxetine, the recommended daily dose for OCD ranges from 20 to 80 mg. Sertraline ranges from 100 to 200 mg, and fluvoxamine from 150 to 300 mg. These upper limits are often higher than what’s prescribed for depression alone.
The timeline is also slower. A full trial of an OCD medication generally requires 10 to 12 weeks at the maximum comfortably tolerated dose before you can know whether it’s truly working. That’s considerably longer than the 4 to 6 weeks often cited for depression. Clinicians typically start at a low dose and increase weekly until the medication reaches its target range, which means the clock on that 10- to 12-week window doesn’t really start until you’ve reached an adequate dose.
SSRIs: The First Choice
SSRIs are the starting point for OCD treatment because they work well for many people and have a more manageable side effect profile than older alternatives. All six SSRIs appear to be roughly equivalent in effectiveness, so the choice between them often comes down to side effects, drug interactions, and individual response. If one SSRI doesn’t work after a full trial, switching to another is a common next step, since people respond differently to each one.
Side effects at standard doses are generally mild and often fade after the first few weeks. Nausea is the most common early complaint and can be reduced by starting at a lower dose and increasing gradually. Sexual side effects (reduced libido, difficulty with orgasm) and weight gain are more persistent concerns, especially at higher doses. In one study of patients on high-dose SSRIs, 34% reported sexual dysfunction, 27% reported weight gain, and 26% reported sedation. Excessive sweating affected about 19%, and tremor occurred in 10%.
Because OCD often requires doses at the upper end of the range or occasionally above it, some side effects become more pronounced. Weight gain can be significant with paroxetine and sertraline, with reports of increases up to 10 kg (about 22 pounds) over a year. Gastrointestinal symptoms like nausea and diarrhea are especially common with fluvoxamine and sertraline at higher doses. At very high doses, heart rhythm changes become a concern, particularly with citalopram and escitalopram, which is why periodic heart monitoring may be recommended.
Clomipramine: An Older but Potent Option
Clomipramine is the only non-SSRI with FDA approval for OCD. It’s an older type of antidepressant (a tricyclic) that also works by increasing serotonin levels in the brain. Some studies have found it slightly more effective than SSRIs for OCD, while others show equivalent results. Despite this, it’s rarely the first medication tried because its side effects are harder to tolerate.
Common problems include dry mouth, constipation, drowsiness, dizziness, and weight gain. More seriously, clomipramine carries a risk of dangerous heart effects in overdose, which makes it a riskier choice for patients with cardiac conditions or suicidal thoughts. For these reasons, clomipramine is typically reserved for people who haven’t responded to at least one or two SSRI trials.
When the First Medication Doesn’t Work
A significant portion of people with OCD don’t respond adequately to the first medication they try. When that happens, there are several paths forward: switching to a different SSRI, increasing the dose, switching to clomipramine, or adding a second medication on top of the existing one (called augmentation).
The most studied augmentation strategy involves adding a low dose of an antipsychotic medication. These drugs were originally developed for conditions like schizophrenia, but at low doses they can boost the effect of an SSRI on OCD symptoms. Aripiprazole is one of the most commonly used, with response rates in studies ranging from about 30% to 80% depending on the study. Newer options in this category are also showing promise. In a study of 34 patients with treatment-resistant OCD, 50% met response criteria after 12 weeks of augmentation with brexpiprazole. Cariprazine showed a 61.5% response rate in a small study of 13 patients.
These augmentation medications come with their own side effects, including weight gain, sedation, and restlessness, so they’re typically used at the lowest effective dose and only when SSRIs alone aren’t enough.
Medications That Target Glutamate
Beyond serotonin-based treatments, researchers have been exploring medications that affect a different brain chemical called glutamate. Memantine, a drug normally used for Alzheimer’s disease, has shown genuine promise. A meta-analysis of three controlled trials found that combining memantine with an SSRI produced better symptom reduction and higher response rates than an SSRI alone, with no significant increase in side effects.
N-acetylcysteine (NAC), an over-the-counter supplement, has generated interest after some dramatic individual case reports. One published case described a woman whose symptom score dropped from severe (32 out of 40) to minimal (9 out of 40) after adding NAC to her existing medication. However, when researchers pooled the results of five controlled trials involving about 200 participants, NAC did not outperform placebo in a statistically meaningful way. It was well tolerated, but the evidence for its effectiveness remains weak.
OCD Medication in Children and Teens
Sertraline and fluvoxamine are the two SSRIs with specific FDA labeling for pediatric OCD. Both have been studied in children using flexible doses of 50 to 200 mg per day. Fluoxetine is also widely used in younger patients, with average doses around 35 mg per day in children under 12 and 64 mg per day in adolescents. Paroxetine has been studied in pediatric trials at doses of 10 to 50 mg per day.
Dosing in children is often guided by body weight, typically ranging from 1 to 3 mg per kilogram per day for sertraline and fluvoxamine. The same general principles apply as in adults: start low, increase gradually, and allow a full trial period before judging effectiveness. Cognitive behavioral therapy is especially important for younger patients, as combined treatment (therapy plus medication) tends to produce better outcomes than either approach alone.
What to Expect During Treatment
Starting an OCD medication is a process that requires patience. You’ll likely begin at a low dose that increases over several weeks. Early side effects like nausea and jitteriness are common but usually temporary. The medication’s effect on OCD symptoms typically builds slowly, and many people don’t notice a meaningful change until they’ve been at an adequate dose for 8 to 12 weeks. Some people experience a partial response, where symptoms improve but don’t fully resolve, which is when augmentation strategies or the addition of therapy becomes particularly valuable.
If the medication works, most guidelines recommend staying on it for at least one to two years before considering a gradual taper. Stopping too early significantly increases the risk of relapse. Many people with OCD benefit from long-term or even lifelong medication, particularly those with severe symptoms or a history of relapse after discontinuation.